Articles

• What’s behind all the M&A deals in pharma?

  As far as M&A deals go, 2019 has started off with a boom.

• 10 of the highest-paid CEOs in pharma

• The Case for Predictive Maintenance

  Leveraging data will not only help pharma predict asset failures, but also eliminate them

• Top 5 Drugs With the Biggest Growth Potential in 2019

  In the coming year, several drugs that treat a range of diseases will far surpass the $1 billion blockbuster mark and continue to grow.